*|MC_PREVIEW_TEXT|*

Medallion CEO | Oshi Series B
April 13, 2023
site logo

Together with

partner logo

“Until you have your first customer, you don’t really have any idea whether you have product-market fit. I think the most obvious way to find that answer is to just start selling.”

Medallion CEO Derek Lo

Startups

DHW Q&A: More Care, Less Friction With Medallion

With Derek Lo
CEO, Medallion

In this Digital Health Wire Q&A, we sat down with Medallion CEO Derek Lo to discuss the emergence of virtual care and how to overcome the friction it brought with it.

Derek founded Medallion in 2020 to help healthcare companies automate credentialing, licensing, and compliance for their provider networks. He’s since helped scale Medallion into one of the largest provider network management companies in the US, with over 300 customers and $85M in funding.

Let’s kick things off with some background on Medallion. Can you share a little about the company and your platform?

First and foremost, Medallion exists to improve access for patients – to allow them to receive care where they want it and in the most cost effective way. Virtual care is here to stay, tons of studies are showing that both physicians and patients support it, but with that comes a whole new problem set.

A major component of that is licensing and making sure that telehealth providers can operate efficiently, but the second piece is insurance.

The multi-payor system in the US creates immense complexity, whether it’s claims and the entire revenue cycle industry, or more in our world: credentialing, enrollment, contracting, negotiation. All of these processes are wrapped around taking insurance as a provider.

That’s really what we’re trying to cut down on. We’re aiming to remove as many of these friction points as possible.

To fill in some more color on the platform, what are some of the ways that you remove this friction?

Like I mentioned, Medallion’s main goal is to automate away all of these operational and regulatory compliance tasks that companies have to do just to run their business. That starts with creating a system record for their provider data, so we’ve built our own CRM from the ground up.

What that’s allowed us to do is build different product lines on top of that, automations that tackle various operational pain points in those two main buckets of licensing and insurance.

On the licensing side, that includes things like getting new state licenses, maintaining and renewing licenses, continuing education tracking – all to help with network operations. On the insurance side, that’s where we’re removing friction by helping establish contracts with new payors, followed typically by enrollment, or in some cases, delegated credentialing.

There’s also a huge need for ongoing support with things like roster management, where provider groups have to share their rosters so everyone can track who’s in-network. That’s still a very manual process that a lot of companies are doing with spreadsheets, same goes for sanctions monitoring and compliance. That’s where we come in.

Looking at Medallion’s growth, it seems like plenty of companies share those pain points. How do you guide the direction of a company that’s growing so quickly?

I think a big part of leadership is finding a way to focus on the top one or two problems at any given moment, and being able to drill down on those problems that are right in front of you.

In one way, building a company is just a long sequence of decisions that plays out over many years. It’s the quality of those decisions, in aggregate, that ultimately decides how successful the company is.

There are obviously external factors – a great example being the SVB crisis – but even those are just another decision along the way. It’s our job to make sure that we get those decisions correct and back them with execution.

What’s a misconception that people have above provider management or credentialing?

At the end of the day, if you talk to any healthcare CEO, these functions are a cost center for their organization. They’re a strategic priority, but only because they’re a key gateway to revenue. Yet for that reason alone, people understand that they’re super important to get right.

We talk to companies all the time where things aren’t running optimally, so they’re worried about leaving revenue on the table because they aren’t getting credentialed fast enough, or claims are getting kicked back because enrollment wasn’t done correctly, and so forth.

It’s really important to tackle these problems, not only because of the missed revenue, but because solving them truly makes an impact in terms of growing efficiently, seeing more patients, and ultimately providing better care.

If Medallion had a secret sauce that you could share with other founders, what would that be?

I don’t think there’s necessarily a magic ingredient, but the biggest thing would have to be the execution component we were talking about earlier. That involves doing deep thinking on the market, and really focusing on the customer above all else

What does the customer need? What are their business problems? How are those problems being solved today? How could they be solved in an optimal scenario?

Every day we try to be as thoughtful as possible about how those answers align with what we’re doing and how we’re trying to serve those needs. We also have a fantastic team, so if we can keep focusing on what I just mentioned, in literally as many decisions as possible, then we’ll get a lot of decisions right in the long run. 

For more on Medallion, head over to their website or swing by booth #1831 at HIMSS.

facebook twitter linkedin read story online

Connect With Synapse Medicine at HIMSS23

Synapse Medicine makes it easy to connect your providers to the drug data and prescribing support they need in their everyday practice. If you’ll be at HIMSS23 next week, make sure to swing by booth #4467 to get an in-person demo and see how Synapse’s clinical decision support solutions can help your providers and their patients optimize drug regimens along the entire care journey.

sponsor logo

Clinical Documentation Integrity For VBC

The growing use of risk-adjusted reimbursement in outpatient settings means clinical documentation needs to keep up, or health systems risk leaving revenue on the table. Check out Nuance’s new blog to learn how shifting reimbursement models make clinical documentation excellence more important than ever, and how AI can help you achieve it.

sponsor logo

How Medallion Helped Skintap Launch in 15 States

In order to launch and scale, Skintap had to build a network of dermatologists who could see patients across the US. Learn how Medallion helped Skintap’s providers get licensed in over 15 states in less than four months – without any headaches and well before their launch date.

sponsor logo

The Wire

  • Oshi Series B: What a week for Oshi Health, the gastrointestinal care startup that announced the completion of its $30M Series B round before the ink was done drying on its first commercial contract with Aetna. Oshi connects patients to gastroenterologist-led virtual care teams that uncover the behavioral health triggers of their symptoms, working primarily as an in-network clinic for payors and employers. “Oshi” roughly translates to “push” in Japanese, which is mainly used in the context of supporting someone in need but seems doubly effective in the GI field.
  • “Fair Share” Deficits Total $14B: A Lown Institute investigation looked at the finances of 1,773 US nonprofit hospitals, finding that 76% spent less on charity care and community investment than they received in tax breaks for 2020. The combined “fair share” deficit totaled $14.2B, which the report says could have wiped out the medical debt of 18M patients or prevented 600 rural hospital closures. Shoutout to New York Presbyterian Hospital for their leading charitable care surplus of $117M.
  • The “Best Buy Effect” for SNF-at-Home: Skilled Nursing News put out a great article on the “Best Buy Effect” that explores how a shortage of skilled nursing facility beds and the growth of managed care programs is driving a boom in SNF-at-home. SNF-at-home requires not only a well-trained deployed workforce, but also expertise in RPM and virtual care. These aren’t core competencies for facility-based SNF teams, but they are for Best Buy / Current Health, which appears to be driving an exodus of nurses to SNF-at-home programs where they can escape the “labor strife” at their facilities and spend more one-on-one time with patients. 
  • Optum Acquires Crystal Run: Optum quietly scooped up its latest physician group in NY-based Crystal Run Healthcare, a multispecialty operation with over 400 providers and 30 locations. The Optum monolith now employs over 70k physicians, significantly ahead of Ascension (49k), HCA (47k) and Kaiser Permanente (24k). Apparently the Crystal Run acquisition closed in February but neither company issued a press release, with Optum steering clear from the CVS strategy of publicizing M&A moves and driving up competition for assets.
  • PE Still Loves Healthcare: Private equity continues to love healthcare, and it looks like the market turmoil has made it a great time to go bargain hunting. Bain & Company’s annual opus on healthcare PE revealed that 2022 was the second-best year on record for healthcare investing, with over $90B in transactions and generative AI / healthcare IT called out as hot sectors. That’s way down from $151B in 2021, but still $10B more than the next-closest year. 
  • Guilty Verdict in $1B Fraud: A trio of former Outcome Health executives were found guilty in a $1B fraud case. Outcome’s main service was video advertising in doctors’ offices, but this WSJ piece portrays the company closer to a criminal venture designed to charge pharmaceutical manufacturers for running ads on more screens than were actually installed and inflating the performance. The cherry on top is that the court also found the CEO guilty of earmarking $225M of a $500M equity investment as a personal dividend… 
  • Volpara Signs Karmanos: Volpara Health will be installing its Risk Pathways risk assessment and patient management software at McLaren Health Care’s Barbara Ann Karmanos Cancer Institute. The software will assess the breast cancer risk profiles of patients who receive mammograms at Karmanos to enable specialists to triage high-risk patients for follow-up care, including genetic testing or additional imaging. Breast care providers have been leaning on risk profiles as a way to identify high-risk women earlier.
  • Microsoft Cloud Payor Features: Microsoft rolled out new cloud features to help payors harness data for better member engagement and care coordination. It’s a huge update – outlined well in this blog post – but the biggest launch is a Unified Member View that provides a customizable aggregation of member data including demographics, claims, conditions, and clinical details. Payors can view member events such as admissions and discharges, with add-on services available for more complex insights like care gap projections or suggested next best actions.
  • CMS Inpatient Hike Falls Flat: CMS is proposing a 2.8% payment increase in 2024 for the Inpatient Prospective Payment System, which covers Medicare reimbursement for inpatient hospital care. CMS says the move increases hospital payments by $3.3B, but the American Hospital Association called it “woefully inadequate” considering the economic pressures hospitals are facing (inflation was just reported at 5% for March) and the fact that half of hospitals finished 2022 in the red.
  • Low Pandemic Alcohol Screenings: Preventive screening for alcohol use plummeted during the pandemic despite a large rise in self-reported binge drinking as well as screening methods that lend themselves to virtual care. New research in Preventive Medicine Reports found that alcohol screening rates in six urban clinics was around 40% prior to the pandemic, but fell to just 2% by May 2020 and 28% during the omicron surge in late 2021. Although screenings have since rebounded to prepandemic levels, the researchers urged providers to bolster their digital screening efforts considering virtual care’s potential in the space.
  • Olive Divests Payor Tools to Availity: Olive AI has reportedly completed its pivot to being a rev cycle pure-play after offloading its payor-facing prior authorization business to health IT company Availity. The acquisition includes all existing contracts and 100 Olive personnel. Olive parted ways with its population health management service in 2021, and it’s now exclusively focused on its Autonomous Revenue Cycle provider-facing tools for prior authorization, admission notices, and eligibility.

Glooko Outcomes Using Real-World Data

Modern diabetes management requires personalized, always-on, and connected care. Explore Glooko’s latest clinical studies to see how remote patient monitoring is making real-word improvements across multiple glycemic outcomes.

sponsor logo

Clear Arch Health Unlocks Turnkey Virtual Care

Clear Arch Health’s turnkey remote patient monitoring and PERS solutions are fully customizable to meet the unique needs of every organization. Discover how Clear Arch Health is helping hospitals, physicians groups, and home health agencies effectively manage patient care – whenever and wherever it’s needed.

sponsor logo

Save Time & Minimize Risk with connectRN

connectRN takes the work out of hiring at scale. connectRN’s W2 staffing solution protects you and your business from liability. Plus, their credentialing team handles everything from state licensure to background checks, and you’ll have access to it all via their user-friendly platform. Learn more.

sponsor logo

SHARE THE WIRE

Share Digital Health Wire
Spread the news & help us grow ⚡
Refer colleagues with your unique link and earn rewards.
Share the Wire
Or copy and share your custom referral link: *|SHAREURL|*
You currently have *|REFERRALS|* referrals.